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There is a subset of patients who would be candidates
for bypass grafts originating from the popliteal artery
except for the presence of focal superficial femoral artery
(SFA) stenosis. This pattern of occlusive disease is typically
managed by performing a longer bypass graft, with the
graft extended proximally to exclude the SFA disease.3-5
Another option is to combine endovascular and open
techniques by performing intraoperative balloon angio-
plasty (IBA) of the focal SFA stenosis and a distal bypass
graft originating from the popliteal artery.
Although SFA balloon angioplasty has not been widely
successful as a sole procedure for diabetic limb salvage,
combining it with distal bypass graft provides some advan-
tages.6-8 The combined procedure permits a shorter bypass
graft to be performed when vein length is inadequate,
decreases the magnitude of the operation in high-risk
patients, and avoids parallel incisions at the ankle, which are
often required for a femoral-pedal bypass graft. If recurrent
SFA stenosis develops later, it may be treated electively, with
either percutaneous transluminal balloon angioplasty (PTA)
or above-knee femoral-popliteal bypass graft.
The purpose of this study was to assess whether com-
bined IBA of the SFA and popliteal to distal bypass graft
Infrainguinal vein bypass graft has assumed a promi-
nent role in the prevention of limb loss due to gangrene in
diabetic patients. This patient group is characterized by
poor long-term survival, severe medical comorbidities,
and diseased infrageniculate runoff vessels that prompt the
use of small-caliber, distal target sites when revasculariza-
tion can be performed. These factors suggest that the
shortest, simplest bypass graft that provides adequate foot
perfusion should be performed. When a tibial or pedal
bypass graft is required, it may originate from the femoral
arteries in the groin, or if the femoral inflow vessels are
free of disease, a popliteal origin bypass graft is a reason-
able option.1,2
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Intraoperative superficial femoral artery balloon
angioplasty and popliteal to distal bypass graft: 
An option for combined open and endovascular
treatment of diabetic gangrene
Peter A. Schneider, MD, Michael T. Caps, MD, MPH, Darren Y. Ogawa, RVT, and Eric S. Hayman,
PA-C, Honolulu, Hawaii
Purpose: The purpose of this study was to evaluate the results of combining intraoperative balloon angioplasty (IBA)
of the superficial femoral artery (SFA) with distal bypass graft originating from the popliteal artery as a method of
lower extremity revascularization in diabetic patients with gangrene.
Methods: Among 380 infrainguinal bypass grafts performed over a 6-year period, there were 110 reversed saphenous
vein bypass grafts to the tibial or pedal arteries to treat diabetic patients with gangrene. Diffuse infrainguinal disease
was treated with femoral-distal bypass graft (long; n = 46). Popliteal-distal bypass graft was performed when the inflow
femoral artery was not significantly diseased (short; n = 52). Focal SFA stenosis and severe infrageniculate disease were
treated with combined IBA of the SFA and distal bypass graft originating from the popliteal artery (combined; n = 12).
Follow-up was performed with duplex scan surveillance of both the bypass graft and IBA sites. Treatment groups were
compared with life-table analysis.
Results: There were no perioperative graft failures or amputations. The perioperative mortality rate was 1% (1 of 110).
The 2-year primary patency rates were similar in the three groups: 72% in the long bypass graft group, 82% in the short
bypass graft group, and 76% in the combined group (P = .8, log-rank test). SFA IBA sites developed recurrent steno-
sis in two patients, at 7 and 48 months; both were detected with surveillance and treated with percutaneous translu-
minal balloon angioplasty. The overall 5-year rate of primary patency was 63%, secondary patency was 78%, limb
salvage was 81%, and survival was 35%. There were no significant differences among the three treatment groups with
respect to these outcomes.
Conclusion: Results with the combined procedure were similar to those achieved with either femoral-distal bypass graft
or popliteal-distal bypass graft without SFA IBA. These data suggest that IBA of the inflow SFA may be combined with
popliteal to distal bypass graft and that this technique is a reasonable alternative to longer, femoral-origin bypass graft
in selected diabetic patients with gangrene. (J Vasc Surg 2001;33:955-62.)
is a reasonable option for limb salvage revascularization in
selected diabetic patients with gangrene.
METHODS
Patients. Over a 6-year period (August 1, 1994, to
July 31, 2000) at a single community hospital, 380
infrainguinal bypass grafts were performed. Among these
patients, there were 110 diabetics with lower extremity
gangrene who underwent reversed saphenous vein bypass
grafts to the tibial or pedal vessels for limb salvage and
who form the basis of this report. Patients with rest pain
or superficial, nonhealing ulcers were excluded because
many of these patients were treated without performing
tibial or pedal bypass grafts. Patients without diabetes and
patients who underwent revascularization procedures
other than infrapopliteal bypass grafts were also excluded
because these patients did not have tibial disease that
required bypass graft. Data collected included atheroscle-
rotic risk factors, patient demographics, hemodynamic
assessment, operative details, and follow-up data, both
clinical and noninvasive. Outcomes included primary and
secondary patency, limb salvage, and survival.
Patient evaluation included clinical assessment, nonin-
vasive testing, and arteriography. Local wound care, antibi-
otics, debridement, and minor amputation were used to
control infection. The damaged extremity was protected by
means of the patient resting in bed, walking on crutches,
or having contact casting to avoid further trauma. Limbs
rendered unsalvageable because of extensive damage to
vital structures or uncontrollable infection were not sub-
jected to infrainguinal bypass graft. Long-term nonambu-
latory patients and those with medical risk that prohibited
surgery were not considered candidates for operation.
Revascularization procedures. Aortoiliac inflow oc-
clusive disease was treated before or simultaneous with
infrainguinal bypass graft surgery. Infrainguinal bypass
grafts were performed with reversed saphenous vein. The
extent of the bypass graft, proximal to distal, was deter-
mined by the pattern of occlusive disease (Fig 1).
Extensive infrainguinal occlusive disease involving both
the femoral-popliteal segment and the infrageniculate
arteries was treated with an infrainguinal bypass graft orig-
inating from the femoral artery in the groin and extending
the length of the limb to a target site in the tibial or pedal
vessels (long bypass graft group, n = 46). These bypass
grafts originated from the common femoral artery (38),
the profunda femoris (3), or the very proximal SFA (5).
SFA occlusive disease was considered too extensive for bal-
loon angioplasty when there was more than one lesion
causing > 50% stenosis or a single lesion that was more
than 3 cm in length. Those with severe infrageniculate
occlusive disease but with patent and well-preserved
femoral-popliteal vessels (0% to 49% stenosis throughout)
underwent bypass graft from the popliteal artery to the
tibial or pedal vessels (short bypass graft group, n = 52).
Patients who required popliteal-distal bypass graft but
who also had a focal SFA lesion were treated with com-
bined, simultaneous, popliteal-distal bypass graft and IBA
JOURNAL OF VASCULAR SURGERY
956 Schneider et al May 2001
Fig 1. Tibial and pedal bypass grafts among 110 diabetic patients with gangrene were performed with three different approaches accord-
ing to pattern of occlusive disease. Long bypass grafts (n = 46) originated from femoral artery in the groin; short bypass grafts (n = 52)
originated from popliteal artery. In the combined group (n = 12), IBA of focal SFA lesion was followed by distal bypass graft originat-
ing from popliteal artery.
of the inflow SFA (combined group, n = 12). Lesions
intended for treatment with IBA were identified preoper-
atively with arteriography and included only single focal
stenoses less than 3 cm in length (Category 1).9 Among
the bypass grafts of popliteal origin performed, 55 were
from the below-knee popliteal artery, and nine were from
the above-knee popliteal artery.
IBA was performed after vein harvest, arterial access,
tunneling, and heparin administration for the popliteal-
distal bypass graft.10 The popliteal artery, which would
serve as the site of proximal anastomosis, was punctured
with an angiographic entry needle, and a 0.035-in diame-
ter floppy-tipped guidewire was advanced retrograde
under fluoroscopy into the SFA (Fig 2). Retraction of the
artery caudally with a Silastic loop (Dow Corning Corp,
Midland, Mich) simplified this maneuver and helped
ensure that only a single-wall puncture was performed. A
5F angiographic access sheath was advanced over the
guidewire. Retrograde femoral arteriography was per-
formed through the sidearm of the sheath with a portable,
digital subtraction technique. Arteriographic images were
enhanced with the placement of the image intensifier close
to the surface of the area of interest and with beam filters.
Contrast usage was minimized by aspirating the contrast
from the femoral-popliteal segment after the images were
obtained. The guidewire was advanced through the SFA
lesion by means of fluoroscopy. A 6-mm balloon angio-
plasty catheter was advanced over the guidewire, through
the sheath and into the lesion. The balloon was brought
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to full profile with fluoroscopic visualization. Completion
arteriography was performed through the sidearm of the
sheath. Contrast required for the procedure ranged from
15 to 40 mL. When completion arteriography demon-
strated a significant residual lesion or flow-limiting dissec-
tion, the 5F sheath was exchanged for a 7F sheath and a
flexible, self-expanding stent was placed at the angioplasty
site (Wallstent; Meditech, Watertown, Mass). Pressure
gradients were not useful in this setting because outflow
occlusion was present in each case because of tibial occlu-
sive disease. Any residual stenosis > 30% was treated with
stent placement. Oblique projections of the angioplasty
site were obtained when the severity of a residual lesion
required further assessment. Stents were placed in five
patients (42%). After a satisfactory completion arteriogram
was obtained, the guidewire and sheath were removed and
the popliteal artery was clamped. The arteriotomy was
extended, and the proximal anastomosis was performed.
Follow-up. Surveillance duplex scans were performed
at 1 month, at 6 months, at 12 months, annually, and as
needed, according to any changes in the clinical examina-
tion or ankle/brachial indices. Arteriography was indi-
cated when there was a duplex scan with abnormal
findings (velocity ratio > 2.0).
Statistical analysis. Risk factors and demographic
variables were compared among treatment groups with
either one-way analysis of variables or the χ2 test. Primary
patency, secondary patency, limb salvage, and patient sur-
vival were estimated with the Kaplan-Meier method.11
Fig 2. Schematic of combined procedure. Patients selected included only those with focal SFA inflow lesions and severe infrageniculate
occlusive disease requiring bypass graft. Guidewire and sheath are inserted retrograde into popliteal artery at site intended for proximal
anastomosis for bypass graft. After IBA, popliteal origin bypass graft is performed.
Treatment groups were compared with respect to these
outcome measures by means of the log-rank test. Cox
regression analysis was used to compute adjusted and non-
adjusted hazard ratios to evaluate the relative risk of graft
failure or limb loss in the combined group compared with
the other treatment groups.
RESULTS
Patient population. Among 110 diabetic patients with
lower extremity gangrene treated in this study, there were 67
men and 43 women, and the mean age was 69 years (range,
43-88). Atherosclerotic risk factors included hypertension in
80%, previous or current cigarette smoking in 27%, coronary
artery disease in 55%, and renal failure requiring long-term
dialysis in 31%. Gangrene was localized to one or more toes
in 31%, to the forefoot in 54%, and to the heel in 15%.
Previous or simultaneous inflow procedures were required in
seven patients (6%) including aortofemoral bypass graft (1),
axillofemoral bypass graft (2), and iliac balloon angioplasty
(4). Contralateral limb ischemia subsequently occurred in
27 patients (25%), which required either revascularization
(23) or amputation (4). The combined treatment group was
compared with both the short and long groups with respect
to these factors, and there were no significant differences
(Table I).
Treatment. Reversed saphenous vein bypass graft was
performed in each case. Target sites included the anterior
tibial artery (16), the peroneal artery (21), the posterior
tibial artery (30), the dorsalis pedis artery (30), and the
plantar arteries (13). There were 63 bypass grafts (67%) to
the ankle or foot and 47 bypass grafts to the tibial arteries.
More bypass grafts to the ankle and foot were performed
in the combined group than in the other treatment groups
(P = .04). Anticoagulation was used postoperatively in 11
patients (10%). The use of anticoagulation was similar
among the groups and did not affect outcome. There was
no perioperative graft failure or limb loss. There was one
perioperative death (1%) due to acute myocardial infarc-
tion (1 of 110).
During follow-up, there were 21 graft failures (19%)
at a mean of 18 months due to either occlusion (12) or
stenosis that was detected with duplex scan surveillance
(9). There were 8 graft failures in the long group, 10 in
the short group, and 3 in the combined group. Graft
revision was performed in 11 patients. In the combined
group, two SFA angioplasty sites developed recurrent
stenosis at 7 and 48 months; both were detected with
duplex scan surveillance and treated with PTA. Another
patient in the combined group had stenosis in the distal
vein graft, which was repaired at 12 months. Overall,
there were nine leg amputations (8%), at a mean of 22
months. Among these, two were performed in patients
with patent bypass grafts but with persistent infection,
and seven were associated with bypass graft occlusion.
Outcome. Mean follow-up was 23 months. Primary
patency for all 110 tibial and pedal bypass grafts was 78%
± 5% at 2 years and 63% ± 8% at 5 years. There was no sig-
nificant difference in primary patency among the treat-
ment groups (P = .8, Fig 3). The 2-year primary patency
was 72% ± 10% in the long group, 82% ± 6% in the short
group, and 76% ± 14% in the combined group. Primary
patency was also compared among the treatment groups
with Cox regression analysis: there was no greater likeli-
hood of graft failure in the combined group than in the
long group or the short group (Table II).
Secondary patency was 89% ± 4% at 2 years and 78% ±
7% at 5 years. The 2-year secondary patencies were not
significantly different among the treatment groups: 86% ±
8% in the long group, 90% ± 5% in the short group, and
100% in the combined group (P = .3, Fig 4).
Limb salvage was 89% ± 4% and 81% ± 6% at 2 and 5
years, respectively. There were no significant differences in
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Table I. Study characteristics stratified by operative group
Factor Combined (N = 12) Short (N = 52) Long (N = 46) P value*
Age (y) (mean ± SD) 70 ± 13 69 ± 11 68 ± 11 .9
Sex (male) 83% 65% 50% .07
Smoker 33% 20% 36% .2
Coronary artery disease 33% 49% 38% .4
Hypertension 17% 16% 24% .6
Renal failure 58% 67% 74% .5
Prior inflow procedure 0% 4% 11% .2
Prior contralateral procedure 33% 21% 26% .6
Location of gangrene .1
Toe 0% 33% 37%
Forefoot 83% 54% 46%
Hindfoot 17% 13% 17%
Target vessel .04
Tibial 25% 35% 57%
Pedal 75% 65% 43%
Preoperative ABI (mean ± SD) 0.52 ± 0.19 0.46 ± 0.15 0.42 ± 0.17 .3
Warfarin sodium (Coumadin) 17% 4% 15% .2
*P values were calculated with one-way analysis of variance for continuous variables and χ2 tests for categorical variables.
ABI, Ankle/brachial index. 
limb salvage in the three treatment groups with life-table
analysis: at 2 years it was 78% ± 9% in the long group, 98%
± 2% in the short group, and 90% ± 9% in the combined
group (P = .6, Fig 5). Limb salvage was compared among
the three treatment groups with Cox regression analysis,
and there was no significant difference with both adjusted
and unadjusted data (Table II). Overall survival was 77% ±
6% at 2 years and 35% ± 8% at 5 years, and there was no
significant difference among the treatment groups (P = .9).
DISCUSSION
The salvage of ischemic, gangrenous lower extremities
in diabetic patients depends on the restoration of distal per-
fusion by whatever means are available. Autogenous vein
bypass graft is usually required from either the femoral or
the popliteal artery to a distal outflow site. The reported 5-
year patency rates for autogenous vein bypass grafts to the
tibial and pedal arteries range from 63% to 69%, and sec-
ondary patency rates range from 72% to 85%.12-15 The
results of the current series are comparable: among 110
patients with infrapopliteal bypass grafts, the 5-year pri-
mary patency was 63%, and the secondary patency was
78%. Limb salvage at 5 years for the entire group was 81%;
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this rate is similar to published results of 80% to 90%.12-15
The 5-year, 35% overall survival reflects the severe medical
illnesses in this group and is similar to other studies in
which survival of 28% to 66% has been documented.12-15
The combination of intraoperative SFA balloon angio-
plasty and distal bypass graft originating from the popliteal
artery provides an alternative to long, lower-extremity
bypass graft in diabetic patients with focal SFA stenosis
proximal to severe infrageniculate occlusive disease.
Outcomes for the combined approach were compared
with those resulting from the long bypass graft (originat-
ing from the femoral artery) and the short bypass graft
(from the popliteal artery). Many of the complex variables
that make it difficult to assess revascularization options
were excluded; all of the study patients were diabetics with
gangrene who underwent reversed saphenous vein bypass
grafts to the infrapopliteal vessels for limb salvage.
Although the combined group included more bypass
grafts to the ankle and foot, the treatment groups were
otherwise similar with respect to other demographic and
risk factors. There was no significant difference in graft
patency or limb salvage between the combined group and
the more traditional long bypass graft group. Among the
Fig 3. Primary patency in long (n = 46), short (n = 52), and com-
bined (n = 12) groups with life-table format. There was no sig-
nificant difference among treatment groups (P = .8 by log-rank
test). Dashed line indicates SE exceeds 10%.
Fig 4. Secondary patency in long, short, and combined groups
with life-table format. There was no significant difference among
groups (P = .3 by log-rank test).
Table II. Cox regression analysis of association of study outcomes with operative group
Unadjusted Adjusted*
Comparison Hazard ratio (95% CI)† P value Hazard ratio (95% CI)† P value
Primary patency
Short bypass graft 1.3 (0.4-4.9) .7 1.3 (0.3-5.4) .8
Long bypass graft 1.6 (0.4-6.2) .5 1.2 (0.2-6.2) .9
Limb salvage
Short bypass graft 1.4 (0.1-13.4) .8 1.3 (0.1-16.6) .9
Long bypass graft 0.7 (0.1-6.1) .7 0.5 (0.0-7.3) .6
*Adjusted for age, sex, cigarette smoking, coronary artery disease, hypertension, hyperlipidemia, renal failure, prior inflow procedure, target vessel, and war-
farin sodium (Coumadin) use. In addition, limb salvage estimates were adjusted for location of gangrene.
†Ratio of graft failure or limb loss for the “Combined” group relative to the group listed.
patients who underwent popliteal to distal bypass graft,
there was no significant difference in outcome whether
IBA of the SFA was performed for inflow.
There are several potential advantages of this ap-
proach. The SFA angioplasty permits a shorter bypass
graft to be performed when ipsilateral vein length is inad-
equate. In this study population, saphenous vein length
was at a premium because 25% of the patients required
contralateral limb revascularization, 55% had documented
coronary artery disease, and dialysis dependency was pre-
sent in 31%, often making upper extremity veins unavail-
able for use as lower extremity conduit. When pedal
bypass graft is required in patients with high medical risk,
the combined technique provides an opportunity to
decrease the magnitude of the open surgical procedure
with the use of endovascular intervention. Performing a
shorter bypass graft avoids distal vein harvesting and the
parallel incisions at the ankle or foot that are often
required for femoral-pedal bypass graft. The poor long-
term survival in this patient population (35% at 5 years)
suggests that revascularization options that are successful
for the short and intermediate time frame are often ade-
quate to meet the patients’ needs. If recurrent stenosis at
the angioplasty site occurs at a later time, it may be treated
electively, after gangrene has healed, with either PTA or
above-knee femoral-popliteal bypass graft.
Although the current study demonstrated that com-
bining endovascular and open techniques was useful in a
subgroup of diabetic patients with gangrene, this tech-
nique is not applicable in many settings. Using SFA bal-
loon angioplasty as inflow for a distal bypass graft depends
on the availability and accuracy of duplex scan surveillance.
In programs where endovascular skills and equipment are
not readily available, a long bypass graft is probably simpler
and safer. The combined group was too small to make con-
clusions about long-term patency. Among patients with a
reasonable likelihood of surviving 5 years or more, this
approach should only be undertaken with the understand-
ing that long-term results are not known and that duplex
scan surveillance would be required.
A major disadvantage of combining SFA angioplasty
with popliteal origin bypass graft is that each IBA site rep-
resents an additional location along the flow stream where
failure may occur. The results of SFA balloon angioplasty
vary widely; success rates range from 47% to 86% at 1 year
and from 38% to 58% at 5 years.16-19 However, when focal
lesions alone were treated, patency rates were substantially
better. Jeans et al20 showed a 76% patency at 5 years for
PTA of SFA stenoses < 1 cm in length versus 50% patency
for longer lesions. Krepel at al21 demonstrated 5-year
patencies of 77% for lesions < 2 cm in length and 54% for
lesions > 2 cm. In the current series, only focal lesions
were considered for treatment with IBA.
Other factors that influence the results of SFA balloon
angioplasty are the use of stents, the quality of distal
runoff, the indication for the procedure, and the presence
of diabetes. Stents have not been shown to provide any
significant benefit to the long-term patency of SFA
PTA.22-24 Stents should be used selectively, as they were in
this study, for extensive dissection or residual stenosis that
threatens the immediate patency of SFA balloon angio-
plasty.25,26 With the decrease of the incidence of immedi-
ate technical failure, stents have made IBA of the SFA a
safer procedure, helping to guarantee the integrity of the
inflow for the popliteal origin bypass graft. Five of the 12
patients who underwent SFA IBA received stents, and
there were no early angioplasty failures.
The indication for revascularization and the quality of
the runoff are two factors that are intricately associated
whenever balloon angioplasty results are considered. The
anatomic hallmark of most limb salvage cases is multilevel
occlusive disease with poor distal runoff, which cannot be
adequately managed with PTA. As a result, SFA PTA in
limb salvage has not been particularly effective as a sole
revascularization procedure.8,20 The results of SFA PTA
have been consistently better when runoff was ade-
quate.16-19,21 In the case of SFA IBA and combined distal
bypass graft, balloon angioplasty is required to manage
only one level of focal, proximal infrainguinal disease,
whereas runoff is enhanced by the construction of a distal
bypass graft. Improved outflow may enhance the long-
term patency of SFA balloon angioplasty. Thus, SFA bal-
loon angioplasty for limb salvage is likely to be more
successful in combination with distal bypass graft than as a
sole revascularization procedure.
It has long been recognized that diabetic patients tend
to have relatively well-preserved femoral vasculature, but
much more severe tibial and pedal occlusive disease than
patients without diabetes.27,28 Although diabetes appears
to be a risk factor for failure after SFA PTA in some stud-
ies, when risk was adjusted for the distribution of lesions
and the quality of runoff, there was no significant differ-
ence between patients with and without diabetes.19,29-32
The success of balloon angioplasty is primarily determined
by the pattern of occlusive disease, rather than the pres-
ence of diabetes or other factors.
The incorporation of endovascular techniques into
open vascular operations has become a routine practice.
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Fig 5. Limb salvage in long, short, and combined groups with
life-table format. There was no significant difference among
groups (P = .6 by log-rank test).
Factors that contributed to this development include the
availability of quality intraoperative fluoroscopic imaging,
the procurement of an inventory of endovascular supplies
in the operating room, the development of stent-grafts,
and the refinement of endovascular skills. Although indi-
cations are limited, the use of SFA IBA could be readily
adopted into vascular programs that have already mastered
other combined procedures.
REFERENCES
1. Pomposelli FB, Marcaccio EJ, Gibbons GW, Campbell DR, Freeman
DV, Burgess AM, et al. Dorsalis pedis artery bypass: durable limb sal-
vage for foot ischemia in patients with diabetes mellitus. J Vasc Surg
1995;21:375-84.
2. Brothers TE, Robinson JG, Elliot BM, Arens C. Is infrapopliteal
bypass compromised by distal origin of the proximal anastomosis?
Ann Vasc Surg 1995;9:172-8.
3. Shah DJ, Darling RC, Chang BB, Kaufman JL, Fitzgerald KM,
Leather RP. Is long vein bypass from the groin to the ankle a durable
procedure? An analysis of a 10 year experience. J Vasc Surg
1992;15:402-7.
4. Schneider JR, Walsh DB, McDaniel MD, Zwolak RM, Besso SR,
Cronenwett JL. Pedal bypass versus tibial bypass with autogenous
vein: a comparison of outcomes and hemodynamic results. J Vasc Surg
1993;17:1029-38.
5. Rutherford RB, Jones DN, Bergentz SE, Berqvist D, Comerota AJ,
Dardik H, et al. Factors affecting the patency of infrainguinal bypass.
J Vasc Surg 1988;8:236-46.
6. Ray SA, Minty I, Buckenham TM, Belli AM, Taylor RS, Dormandy JA.
Clinical outcome and restenosis following percutaneous transluminal
angioplasty for ischemic pain or ulceration. Br J Surg 1995;82:1217-21.
7. Matsi PJ, Manninen HI, Suhonen MT, Pirinen AE, Soimakallio S.
Chronic critical lower extremity ischemia: prospective trial of angio-
plasty with 1-36 months follow-up. Radiology 1993;188:381-97.
8. Parsons RE, Suggs WD, Lee JJ, Sanchez LA, Lyon RT, Veith FJ.
Percutaneous transluminal angioplasty for the treatment of limb
threatening ischemia: do the results justify an attempt before bypass
grafting? J Vasc Surg 1998;28:1066-71.
9. Schneider PA, Rutherford RB. Endovascular intervention in the man-
agement of chronic lower extremity ischemia. In: Rutherford RB, editor.
Vascular surgery. 5th ed. Philadelphia: WB Saunders; 2000. p. 1041-3.
10. Schneider PA. Balloon angioplasty and stent placement during opera-
tive vascular reconstruction for lower extremity ischemia. Ann Vasc
Surg 1996;10:589-98.
11. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S,
et al. Recommended standards for reports dealing with lower extrem-
ity ischemia: revised version. J Vasc Surg 1997;26:517-38.
12. Dalman RL, Taylor LM. Basic data related to infrainguinal revascular-
ization procedures. Ann Vasc Surg 1990;4:309-12.
13. Taylor LM, Edwards JM, Porter JM. Present status of reversed vein
bypass grafting: five-year results of a modern series. J Vasc Surg
1990;11:193-205.
14. Donaldson MC, Mannick JA, Whittemore AD. Femoral-distal bypass
with in-situ greater saphenous vein: long-term results using the Mill’s
valvulotome. Ann Surg 1991;213:457-64.
JOURNAL OF VASCULAR SURGERY
Volume 33, Number 5 Schneider et al 961
15. Bergamini TM, Towne JB, Bandyk DF, Seabrook GR, Schmitt DD.
Experience with saphenous vein in-situ bypasses during 1981-1989:
determinant factors of long-term patency. J Vasc Surg 1991;13:137-47.
16. Matsi PJ, Manninen HI, Vanninen RL, Suhonen MT, Oksala I,
Laakso M, et al. Femoropopliteal angioplasty in patients with claudi-
cation: primary and secondary patency in 140 limbs with 1-3 year fol-
low-up. Radiology 1994;191:727-33.
17. Murray JG, Apthorp LA, Wilkins RA. Long-segment femoropopliteal
angioplasty: improved technical success and long-term patency.
Radiology 1995;195:158-62.
18. Johnston KW. Femoral and popliteal arteries: reanalysis of results of
balloon angioplasty. Radiology 1992;183:767-71.
19. Gallino A, Mahler F, Probst P, Nachbur B. Percutaneous transluminal
angioplasty of the arteries of the lower limbs: a five-year follow-up.
Circulation 1984;70:619-23.
20. Jeans WD, Armstrong S, Cole SEA, Horrocks M, Baird RN. Fate of
patients undergoing transluminal angioplasty for lower limb ischemia.
Radiology 1990;177:559-64.
21. Krepel VM, van Andel GJ, van Erp WF, Breslau PJ. Percutaneous
transluminal angioplasty of the femoropopliteal artery: initial and
long-term results. Radiology 1985;156:325-8.
22. Rousseau HP, Raillat CR, Joffre FG, Knight CJ, Ginestet MC.
Treatment of femoropopliteal stenoses by means of self-expandable
endoprostheses: midterm results. Radiology 1989;172:961-4.
23. Zollikofer CL, Antonucci F, Pfyffer M, Redha F, Salomonowitz E,
Stuckmann G, et al. Arterial stent placement with the use of the Wallstent:
midterm results and clinical experience. Radiology 1991;179:449-56.
24. Vroegindweij D, Vos LD, Tiekbeek LD, Buth J, vd Bosch HC.
Balloon angioplasty combined with primary stenting versus balloon
angioplasty alone in femoropopliteal obstructions: a comparative ran-
domized study. Cardiovasc Intervent Radiol 1997;20:420-5.
25. Sapoval MR, Long AL, Raynaud AC, Beysson BM, Feissinger JN,
Gaux JC. Femoropopliteal stent placement: long-term results.
Radiology 1992;184:834-9.
26. Liermann D, Strecker EP, Peters J. The Strecker stent: indications and
results in iliac and femoropopliteal arteries. Cardiovasc Intervent
Radiol 1992;15:298-395.
27. Haimovoci H. Patterns of arteriosclerotic lesions in the lower extrem-
ity. Arch Surg 1967;95:918-33.
28. Stoney RJ, James DR, Wylie EJ. Surgery for femoropopliteal athero-
sclerosis: a reappraisal. Arch Surg 1971;103:548-53.
29. Rush DS, Gewertz BL, Lu CT, Ball DG, Zarins CK. Limb salvage in
poor risk patients using transluminal angioplasty. Arch Surg
1983;118:1209-12.
30. Capek P, McLean GK, Berkowitz HG. Femoropopliteal angioplasty: fac-
tors influencing long-term success. Circulation 1991;83 Suppl 2:170-80.
31. Stokes KR, Strunk HM, Campbell DR, Gibbons GW, Wheeler HG,
Clouse ME. Five-year results of iliac and femoropopliteal angioplasty
in diabetic patients. Radiology 1990;174:977-82.
32. Davies AH, Cole SE, Magee TR, Scott DJ, Baird RN, Horrocks M.
The effect of diabetes mellitus on the outcome of angioplasty for
lower limb ischemia. Diabet Med 1992;9:480-1.
Submitted Sep 22, 2000; accepted Dec 7, 2000.
DISCUSSION
Dr. E. John Harris, Jr (Stanford, Calif). Treatment of ischemic
limbs in patients with diabetes is a difficult problem often requiring
multiple tedious bypass procedures to effect limb salvage. Many
occasional vascular surgeons avoid these procedures altogether and
suggest primary amputation, which may often be a reasonable rec-
ommendation. Those of us with an established interest in limb sal-
vage surgery often thrive on the challenge of limb salvage in these
difficult patients and will routinely consider distal tibial and pedal
bypass with composite autogenous vein grafts as a suitable solution.
When confronted with little suitable autogenous vein, one often
considers more distal origins for the graft, but in these patients, the
SFA is often diseased above a potential popliteal origin. Dr
Schneider and his group bring to us today a concept for treatment
of ischemic diabetic limbs in patients with focal superficial femoral
artery disease and distal tibial or pedal targets for bypass. In most
of our practices, such a patient would receive a long autogenous
bypass from a proximal femoral artery inflow source to the distal
tibial or pedal target. In this series, the majority of patients did have
a long bypass when the popliteal artery was not a suitable inflow
source or a popliteal to pedal or tibial bypass when there was no sig-
nificant SFA disease, and only 12 patients had adjunctive SFA
angioplasty with a popliteal to tibial or pedal bypass.
The criterion for SFA angioplasty was a focal stenosis < 2 cm
in length, with the procedure performed retrograde from a surgi-
cally exposed popliteal artery. Technical success was excellent,
there were no failures, and the durability of this procedure was
not significantly different from the other distal bypass groups
described. I note that two of the three failed grafts in the com-
bined angioplasty-popliteal-distal bypass group occurred in the
SFA angioplasty site, yet only 42% of the SFA angioplasties were
treated with adjunctive Wallstents. In retrospect, would these fail-
ures have been prevented by a procedure that employs stents in
all angioplasty sites rather than selective use as you describe? Were
there any failures in stented angioplasty sites?
Limb salvage was similar in all three groups (81% at 5 years)
and quite good for such a difficult group of patients. Only two of
the nine amputations were performed in patients with patent
bypass grafts. This is different from my own experience where I
find that open pedal wounds, especially on the calcaneus with a
graft to the anterior tibial or dorsal pedal artery, often fail to heal
in spite of a patent graft. What were your results in the 16 heel
wounds? Did they all heal after bypass?
This was a typical diabetic patient population, with limb sal-
vage as the main indication for intervention, yet there was a sur-
prisingly low incidence of tobacco abuse. With only 30% of the
population smoking, why is there such a severe 5-year mortality
rate of 35% in your patients?
I commend Dr Schneider for this careful recommendation of
combined SFA angioplasty above a popliteal to tibial or pedal
bypass. His results are excellent, and they reflect his conservative
and well–thought-out use of this procedure. The manuscript is
informative and well written, and I recommend it to you all once
it is published.
Dr Peter A. Schneider. The first question that Dr Harris asked
is whether or not all superficial femoral artery lesions should be
stented. The reason we stented them selectively and probably will
continue to do so is that there have been two randomized trials
that showed no difference in the 1-year patency of stented and
nonstented lesions.
The key benefit of stenting is that it is a procedure that can
very reliably be performed with immediate success. It’s perfect
for the operating room. With a stent you’re going to get a
beautiful result with close to 100% certainty and that makes it
something that you can reliably base inflow for a distal bypass
graft on.
The second question was about the patients with the heel
wounds. This is a very difficult group. One of the things that
helped a lot is that we do have in our institution a diabetic limb
treatment program that mandates a referral for every diabetic
with a foot wound, whether they have pulses or not. They are
referred to our diabetic limb treatment program. We have a nurse
coordinator, an infectious disease doctor, vascular surgeons, two
podiatrists, and an orthopedist. We have clinic once a week.
It’s almost impossible for people to circulate for too long
with a foot problem because the referral is essentially mandated.
A lot of these lesions that I might have seen later I’m seeing
sooner, and I’m having an opportunity before the foot damage is
so severe that they can’t be fixed. This is the way to save feet with
heel lesions.
The last question was about the mortality in this group. I
think it’s because there were a lot of patients with renal failure.
When we looked at our renal failure population, the mortality in
that group was really quite high. 
Dr Sam Ahn (Los Angeles, Calif). Dr Schneider, those are
excellent results. I would like to offer an alternative to your tech-
nique. For patients with wet, gross gangrene, certainly you need
to treat both the SFA and tibial disease at the same time. But for
patients with dry gangrene with fairy small areas of necrosis or
gangrene or chronically nonhealing ulcers, I propose performing
just the balloon angioplasty of the SFA lesion, then waiting and
seeing what happens. In my experience about half of those
patients will heal without doing the distal popliteal tibial bypass.
Would you consider that as another option?
Dr Schneider. That’s an excellent point, and, in fact, one of
the things that we’re looking at currently in my institution is the
use of angioplasty as the sole method of limb revascularization. I
think there is a small subset of patients that fit the category of
exactly what you’re talking about.
The hard question is when someone shows up in your office,
how do you know which is which, how much revascularization is
enough, and that’s sort of a basic question that we always have to
go through.
Dr Ronald Dalman (Stanford, Calif). Peter, I think this makes
a lot of sense for a patient who has a relatively short segment of
suitable vein available. I’m just curious, based on your experience,
what’s your preference if a patient needs a distal bypass but has a
suitable length of autogenous vein for a traditional proximal anas-
tomosis at the common superficial/superficial femoral?
Just as a comparison, one of our colleagues in the San Jose
area who does this seems to do this preferentially now to a longer
bypass. He’s taken to angioplasty most SFA lesions and basing
bypasses distal to that even when suitable vein is available for
longer bypass. I’m just curious what your preferences are based
on your experience.
Dr Schneider. If I have a patient who I think is going to be
around for more than 5 years, I would probably do a long bypass.
Dr Raker. I have two questions. One is, how did you assess
how well your SFA balloon angioplasty was? Did you do pressures
afterwards looking for other occult lesions in the SFA that might
not be seen by imaging?
Then the second question is, did you exclude neuropathic
patients from your series, and if not, why don’t we see more neu-
ropathic ulcers in the revascularized patients postoperatively?
Dr Schneider. All of the patients in the series are patients who
had critical ischemia with accompanying gangrene. Some of them
had neuropathy, but I think in general, it was a very ischemic group.
They had low toe pressures and low ABIs.
We did not measure pressures. We did do, though, early
postoperative duplex scanning. So we looked at our velocities
through the angioplasty site, and when the patients came back
for their surveillance of their distal bypass grafts, they also had
surveillance at the angioplasty site itself. That was how we
picked up two recurrent stenoses that subsequently underwent
repeat angioplasty.
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